What does Original BioMedicals Co., Ltd. do?

Original BioMedicals Co., Ltd. (6483.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6483.TWO's market cap?

Original BioMedicals Co., Ltd. (6483.TWO) has a market capitalization of approximately $932.0 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6483.TWO pay a dividend?

No — Original BioMedicals Co., Ltd. (6483.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6483.TWO profitable?

Original BioMedicals Co., Ltd. (6483.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6483.TWO

Original BioMedicals Co., Ltd.

TWO·Drug Manufacturers, Specialty & Generic · Healthcare

NT$13.95NT$0.25+1.82%

Market capNT$931.97M·Market closed·Aug 26 6:37 AM UTC

Price Chart

NT$13.95+NT$0.25 (+1.82%)today

−18.90%CAGR −8.31%

Select date range

FromTo

Mar 27, 2024Mar 27, 2024 → Aug 26, 2026· 2.4 yrsAug 26, 2026

Key Metrics

6483.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$0.00

Net Income−NT$102.24M

Net Margin—

Operating Cash Flow−NT$122.49M

Capital ExpendituresNT$3.11M

Free Cash Flow−NT$125.60M

Return on Equity−92.1%

Return on Invested Capital−40.0%

Net CashNT$61.61M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6483.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6483.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6483.TWO and 80,000+ other tickers.

About Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.

CEO: Cliff C. Wang
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: TWO
Employees: 25
Website: www.i-obm.com/English_Version/index.aspx

Peers

Bioray Biotech Co., Ltd

Cap

NT$500.0M

8409.TWO

EBM Technologies Incorporated

Cap

NT$587.2M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6483.TWO

What does Original BioMedicals Co., Ltd. do?: Original BioMedicals Co., Ltd. (6483.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6483.TWO's market cap?: Original BioMedicals Co., Ltd. (6483.TWO) has a market capitalization of approximately $932.0 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6483.TWO pay a dividend?: No — Original BioMedicals Co., Ltd. (6483.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6483.TWO profitable?: Original BioMedicals Co., Ltd. (6483.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.